Published in J Virol on February 01, 2001
Epstein-Barr virus latent genes. Exp Mol Med (2015) 0.96
Caspase-mediated degradation of human 5-lipoxygenase in B lymphocytic cells. Proc Natl Acad Sci U S A (2005) 0.85
Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1. J Virol (2009) 0.82
Downregulation of the polyamine regulator spermidine/spermine N(1)-acetyltransferase by Epstein-Barr virus in a Burkitt's lymphoma cell line. Virus Res (2013) 0.77
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell (1993) 20.72
Induction of apoptosis in fibroblasts by c-myc protein. Cell (1992) 16.95
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (1988) 14.66
Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell (1991) 7.40
bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell (1989) 6.66
Cellular oncogenes and multistep carcinogenesis. Science (1983) 6.52
Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J Virol (1989) 5.67
The role of gene dosage and genetic transpositions in carcinogenesis. Nature (1981) 5.58
Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature (1992) 5.50
Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene (1991) 5.32
Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol (1990) 5.26
Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature (1992) 4.75
Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature (1991) 4.06
Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J Virol (1994) 2.81
An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Virus Genes (1991) 2.77
Bcl-2 and Bax function independently to regulate cell death. Nat Genet (1997) 2.64
Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. J Virol (1999) 1.86
Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma. Mol Cell Biol (1999) 1.80
Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells. J Virol (1996) 1.79
Heterodimerization-independent functions of cell death regulatory proteins Bax and Bcl-2 in yeast and mammalian cells. J Biol Chem (1997) 1.78
Oncogenic potential of bcl-2 demonstrated by gene transfer. Nature (1988) 1.60
Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata. J Virol (1998) 1.55
Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype. J Infect Dis (1998) 1.29
A unique EBV-negative low-grade lymphoma line (WSU-FSCCL) exhibiting both t(14;18) and t(8;11). Cancer Genet Cytogenet (1993) 1.14
The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo. Exp Cell Res (1995) 1.05
Apoptosis in Burkitt lymphoma cells is driven by c-myc. Oncogene (1993) 1.03
Prevention of programmed cell death in Burkitt lymphoma cell lines by bcl-2-dependent and -independent mechanisms. Int J Cancer (1992) 1.03
Combination of t(14;18) and a Burkitt's type translocation in B-cell malignancies. Leuk Lymphoma (1993) 0.96
Translocations t(14;18) and t(8;14) with rearranged bcl-2 and c-myc in a case presenting as B-ALL (L3). Leukemia (1991) 0.90
trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. J Virol (1986) 5.25
Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int J Cancer (1984) 3.49
New measurement system for fault location in optical waveguide devices based on an interferometric technique. Appl Opt (1987) 3.15
Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J Virol (1994) 2.81
Finer features for functional microdevices. Nature (2001) 2.73
Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes. J Cell Biol (2001) 2.73
Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol (1998) 2.61
Brain MR in Fukuyama congenital muscular dystrophy. AJNR Am J Neuroradiol (1996) 2.42
Intraoperative torsade de pointes ventricular tachycardia and ventricular fibrillation during sevoflurane anesthesia. Anesth Analg (1998) 2.26
New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology (2005) 2.14
New fluorogenic substrates for alpha-thrombin, factor Xa, kallikreins, and urokinase. J Biochem (1977) 1.96
Chromogenic substrates for horseshoe crab clotting enzyme. Its application for the assay of bacterial endotoxins. Haemostasis (1978) 1.96
Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. J Virol (1999) 1.86
Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells. J Virol (1996) 1.79
Phenotypes of Epstein-Barr virus LMP1 deletion mutants indicate transmembrane and amino-terminal cytoplasmic domains necessary for effects in B-lymphoma cells. J Virol (1992) 1.77
Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J Virol (1997) 1.69
Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction. EMBO J (2000) 1.66
Highly sensitive peptide-4-methylcoumaryl-7-amide substrates for blood-clotting proteases and trypsin. Eur J Biochem (1988) 1.62
Epstein-Barr virus-associated gastric carcinoma and atrophic gastritis. J Clin Gastroenterol (1999) 1.59
Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata. J Virol (1998) 1.55
A study of carboplatin-coated tube for the unresectable cholangiocarcinoma. Hepatology (2000) 1.51
Preparation and evaluation of a time-controlled release capsule made of ethylcellulose for colon delivery of drugs. J Drug Target (1995) 1.48
Postoperative intussusception after incidental appendicectomy. Pediatr Surg Int (2002) 1.47
Angiotensin II binding activity in cultured porcine arterial endothelial cells. Biochem Pharmacol (1994) 1.44
Nationwide surveillance of antimicrobial consumption and resistance to Pseudomonas aeruginosa isolates at 203 Japanese hospitals in 2010. Infection (2013) 1.42
Suppressive effect of ethanol on the expression of hepatic asialoglycoprotein receptors augmented by interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha. J Gastroenterol (1998) 1.42
Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies. Arthritis Rheum (2002) 1.42
Activation of latent EBV via anti-IgG-triggered, second messenger pathways in the Burkitt's lymphoma cell line Akata. J Immunol (1990) 1.40
Smoothness of human jaw movement during chewing. J Dent Res (1999) 1.40
Genetic analysis of a dentatorubral-pallidoluysian atrophy family: relevance to apparent sporadic cases. Intern Med (1999) 1.39
Purification and characterization of furin, a Kex2-like processing endoprotease, produced in Chinese hamster ovary cells. J Biol Chem (1992) 1.36
In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine. Antimicrob Agents Chemother (1993) 1.33
Capuramycin, a new nucleoside antibiotic. Taxonomy, fermentation, isolation and characterization. J Antibiot (Tokyo) (1986) 1.32
Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling. Oncogene (2008) 1.31
Epstein-Barr virus lacking glycoprotein gp85 cannot infect B cells and epithelial cells. Virology (2000) 1.30
Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet. Cancer Res (2001) 1.30
Both the rightward and the leftward open reading frames within the BamHI M DNA fragment of Epstein-Barr virus act as trans-activators of gene expression. J Virol (1987) 1.29
Early events in Epstein-Barr virus genome expression after activation: regulation by second messengers of B cell activation. Virology (1991) 1.29
Roles of Epstein-Barr virus glycoproteins gp350 and gp25 in the infection of human epithelial cells. J Gen Virol (2001) 1.27
Difference in tumor incidence and other tissue responses to polyetherurethanes and polydimethylsiloxane in long-term subcutaneous implantation into rats. J Biomed Mater Res (1992) 1.24
Resolution of Streptococcus mutans glycosyltransferases into two components essential to water-insoluble glucan synthesis. FEBS Lett (1981) 1.22
Analysis of the BZLF1 promoter of Epstein-Barr virus: identification of an anti-immunoglobulin response sequence. J Virol (1993) 1.21
Epstein-Barr virus infection in non-carcinomatous gastric epithelium. J Pathol (1997) 1.20
Identification of an enhancer-type sequence that is responsive to Z and R trans-activators of Epstein-Barr virus. Virology (1989) 1.19
Three Epstein-Barr virus (EBV)-determined nuclear antigens induced by the BamHI E region of EBV DNA. Int J Cancer (1988) 1.18
Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression. Virology (1999) 1.17
Isolated heterotopic pancreas causing intussusception. Eur J Pediatr Surg (2000) 1.17
Persistent Epstein-Barr virus infection in a human T-cell line: unique program of latent virus expression. EMBO J (1995) 1.16
Epstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expression. J Virol (1999) 1.09
Characterization of two novel polysaccharides having immunological activities from the root of Panax ginseng. Biol Pharm Bull (1993) 1.08
Formation of intranuclear replication compartments of Epstein-Barr virus with redistribution of BZLF1 and BMRF1 gene products. Virology (1991) 1.07
A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am J Hum Genet (2001) 1.06
Taxonomy of Trichophyton interdigitale (Trichophyton mentagrophytes var. interdigitale) by restriction enzyme analysis of mitochondrial DNA. J Med Vet Mycol (1990) 1.06
Analysis of epstein-Barr virus (EBV) of P3HR-1: isolation of EBV with EBNA induction ability in human cord lymphocytes and without EA induction ability in Raji cells. Virology (1982) 1.06
Dentoskeletal and tongue soft-tissue correlates: a cephalometric analysis of rest position. Am J Orthod (1985) 1.05
Porphyromonas gingivicanis sp. nov. and Porphyromonas crevioricanis sp. nov., isolated from beagles. Int J Syst Bacteriol (1994) 1.05
Cortical dysplasia in congenital muscular dystrophy with central nervous system involvement (Fukuyama type). J Neuropathol Exp Neurol (1984) 1.05
Choledochal cyst associated with duodenal atresia: case report and review of the literature. Pediatr Surg Int (2009) 1.05
Unexpected and variable phenotypes in a family with JAK3 deficiency. Genes Immun (2001) 1.05
A membrane-bound, calcium-dependent protease in yeast alpha-cell cleaving on the carboxyl side of paired basic residues. Biochem Biophys Res Commun (1987) 1.05
Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis. Clin Exp Immunol (2002) 1.05
A new fluorogenic substrate method for the estimation of kallikrein in urine. J Biochem (1980) 1.05
Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol (2000) 1.04
Complete 3-D reconstruction of dental cast shape using perceptual grouping. IEEE Trans Med Imaging (2001) 1.04
Three kinds of antibacterial substances from Lentinus edodes (Berk.) Sing. (Shiitake, an edible mushroom). Int J Antimicrob Agents (1999) 1.04
Effect of the CYP2D6*10 genotype on venlafaxine pharmacokinetics in healthy adult volunteers. Br J Clin Pharmacol (1999) 1.02
Lytic Epstein-Barr virus infection in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum (2000) 1.02
Epstein-Barr virus (EBV) infection in salivary gland tumors: lytic EBV infection in nonmalignant epithelial cells surrounded by EBV-positive T-lymphoma cells. Virology (1997) 1.02
Shikonin, an ingredient of Lithospermum erythrorhizon, inhibits angiogenesis in vivo and in vitro. Anticancer Res (1998) 1.00
A novel emulsifier, labrasol, enhances gastrointestinal absorption of gentamicin. Life Sci (2001) 0.99
Endoscopic and pathologic features of Epstein-Barr virus-associated gastric carcinoma. Gastrointest Endosc (1997) 0.98
Large cell carcinoma of the lung associated with marked eosinophilia. A case report. Cancer (1984) 0.98
Tongue volume in human female adults with mandibular prognathism. J Dent Res (1996) 0.98
Monoclonal antibody specific for capsid antigen of Epstein-Barr virus. Med Microbiol Immunol (1983) 0.98
Inhibition of acid production in dental plaque bacteria by green tea catechins. Caries Res (2006) 0.98
A novel arterial infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma after vascular supply distribution via superselective embolization. Cancer (2000) 0.97
Enhancement of hepatitis C virus replication by Epstein-Barr virus-encoded nuclear antigen 1. EMBO J (1999) 0.96
Reinforcing effect as a function of infusion speed in intravenous self-administration of nicotine in rhesus monkeys. Nihon Shinkei Seishin Yakurigaku Zasshi (1995) 0.96
Further characterization of the receptor mechanism involved in the antidysrhythmic effect of dexmedetomidine on halothane/epinephrine dysrhythmias in dogs. Anesthesiology (1995) 0.95
Capacitation-related changes in antigen distribution on mouse sperm heads and its relation to fertilization rate in vitro. J Reprod Immunol (1987) 0.95
Detection of Epstein-Barr virus DNA in hepatocellular carcinoma tissues from hepatitis C-positive patients. Scand J Gastroenterol (2000) 0.95
[A case of miliary tuberculosis with prolonged high fever for more than 2 months under antituberculous therapy]. Kekkaku (1990) 0.95
Plant mucilages. XLIII. A representative mucilage with biological activity from the leaves of Hibiscus rosa-sinensis. Biol Pharm Bull (1993) 0.95
Induction of Epstein-Barr virus antigens by tumor promoters for epidermal and nonepidermal tissues. Int J Cancer (1984) 0.95
A new and highly sensitive fluorescence assay for collagenase-like peptidase activity. Anal Biochem (1979) 0.94
Analysis of the transformation of human lymphocytes by Epstein-Barr virus. I. Sequential occurrence from the virus-determined nuclear antigen synthesis, to blastogenesis, to DNA synthesis. Intervirology (1979) 0.94
A case of cross stimulation. Pacing Clin Electrophysiol (1989) 0.93
New fluorogenic peptide substrates for plasmin. J Biochem (1980) 0.93
CD21-mediated entry and stable infection by Epstein-Barr virus in canine and rat cells. J Virol (2000) 0.93
Association of Epstein-Barr virus (EBV) with Sjögren's syndrome: differential EBV expression between epithelial cells and lymphocytes in salivary glands. Am J Pathol (1996) 0.93
Limited pancreatectomy: significance of postoperative maintenance of pancreatic exocrine function. J Hepatobiliary Pancreat Surg (2000) 0.92
Tongue muscle activity after orthodontic treatment of anterior open bite: a case report. Am J Orthod Dentofacial Orthop (1999) 0.92
Case report: hypoechoic submucosal nodules: a sign of Epstein-Barr virus-associated early gastric cancer. J Gastroenterol Hepatol (1998) 0.92
Cerebellar MR in Fukuyama congenital muscular dystrophy: polymicrogyria with cystic lesions. AJNR Am J Neuroradiol (1994) 0.92
Adrenocortical suppression blocks the enhancement of memory storage produced by exposure to psychological stress in rats. Brain Res (1999) 0.92
Spontaneous establishment of an Epstein-Barr virus-infected fibroblast line from the synovial tissue of a rheumatoid arthritis patient. J Virol (1997) 0.92
Coordination of cortically induced rhythmic jaw and tongue movements in the rabbit. J Neurophysiol (1993) 0.92